Cargando…

Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.

The lognormal parametric statistical model can provide, for groups of carcinoma cervix patients, good estimates of long-term survival fractions several years earlier than would otherwise be possible. The present paper extends this model work to head and neck cancer by using a minimum chi-squared tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Mould, R. F., Hearnden, T., Palmer, M., White, G. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1976
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025142/
https://www.ncbi.nlm.nih.gov/pubmed/962995
_version_ 1782136705009057792
author Mould, R. F.
Hearnden, T.
Palmer, M.
White, G. C.
author_facet Mould, R. F.
Hearnden, T.
Palmer, M.
White, G. C.
author_sort Mould, R. F.
collection PubMed
description The lognormal parametric statistical model can provide, for groups of carcinoma cervix patients, good estimates of long-term survival fractions several years earlier than would otherwise be possible. The present paper extends this model work to head and neck cancer by using a minimum chi-squared test for goodness of fit (P greater than 0-05), to study the distribution of survival times of patients who died with their cancer present. Some 12,000 case histories were available from 7 hospital registries, 4 regional cancer registries and one national registry (the OPCS). All histories were followed up for at least 10 years subsequent to treatment and could be grouped into one of 8 cancer sites: antrum, floor of mouth, larynx, nasopharynx, pyriform fossa, post cricoid, tonsil and tongue. The theoretical distributions investigated were the lognormal, negative exponential and skew exponential. The results showed that the lognormal provided the best overall fit to the data, although the range of optimum values for the lognormal parameter, S, differed with cancer site. The optimum range did, however, usually include the value S=0-45. These results will now permit the second stage of validation of the lognormal model to proceed for head and neck cancers.
format Text
id pubmed-2025142
institution National Center for Biotechnology Information
language English
publishDate 1976
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20251422009-09-10 Distribution of survival times of 12,000 head and neck cancer patients who died with their disease. Mould, R. F. Hearnden, T. Palmer, M. White, G. C. Br J Cancer Research Article The lognormal parametric statistical model can provide, for groups of carcinoma cervix patients, good estimates of long-term survival fractions several years earlier than would otherwise be possible. The present paper extends this model work to head and neck cancer by using a minimum chi-squared test for goodness of fit (P greater than 0-05), to study the distribution of survival times of patients who died with their cancer present. Some 12,000 case histories were available from 7 hospital registries, 4 regional cancer registries and one national registry (the OPCS). All histories were followed up for at least 10 years subsequent to treatment and could be grouped into one of 8 cancer sites: antrum, floor of mouth, larynx, nasopharynx, pyriform fossa, post cricoid, tonsil and tongue. The theoretical distributions investigated were the lognormal, negative exponential and skew exponential. The results showed that the lognormal provided the best overall fit to the data, although the range of optimum values for the lognormal parameter, S, differed with cancer site. The optimum range did, however, usually include the value S=0-45. These results will now permit the second stage of validation of the lognormal model to proceed for head and neck cancers. Nature Publishing Group 1976-08 /pmc/articles/PMC2025142/ /pubmed/962995 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Mould, R. F.
Hearnden, T.
Palmer, M.
White, G. C.
Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
title Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
title_full Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
title_fullStr Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
title_full_unstemmed Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
title_short Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
title_sort distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025142/
https://www.ncbi.nlm.nih.gov/pubmed/962995
work_keys_str_mv AT mouldrf distributionofsurvivaltimesof12000headandneckcancerpatientswhodiedwiththeirdisease
AT hearndent distributionofsurvivaltimesof12000headandneckcancerpatientswhodiedwiththeirdisease
AT palmerm distributionofsurvivaltimesof12000headandneckcancerpatientswhodiedwiththeirdisease
AT whitegc distributionofsurvivaltimesof12000headandneckcancerpatientswhodiedwiththeirdisease